Conversion hepatectomy for hepatocellular carcinoma with inadequate future- remnant- liver after portal vein ligation in combination with apatinib plus camrelizimab: A single-arm prospective pilot study (PLACES).

Zhiming Zeng,Guangzhi Zhu,Hua-Sheng Huang,Yangfeng Jiang,Xinping Ye,Jie Zeng,Cuizhen Liu,Hao Su,Ming Su,Ning Mo,Xiwen Liao,Fu-chao Ma,Minhao Peng,Jie Ma,Tao Peng

Conversion hepatectomy for hepatocellular carcinoma with inadequate future- remnant- liver after portal vein ligation in combination with apatinib plus camrelizimab: A single-arm prospective pilot study (PLACES).

2021

Zhiming Zeng
Guangzhi Zhu
Hua-Sheng Huang
Yangfeng Jiang
Xinping Ye
Jie Zeng
Cuizhen Liu
Hao Su
Ming Su
Ning Mo
Xiwen Liao
Fu-chao Ma
Minhao Peng
Jie Ma
Tao Peng

e16132Background: A variety of staged hepatic resection has been applied in patients (pts) with hepatocellular carcinoma (HCC) who had an inadequate future-remnant-liver (FRL), but the clinical out...

Keywords:

remnant liver
Medicine
hepatic resection
Hepatocellular carcinoma
Internal medicine
Gastroenterology
in patient
Hepatectomy
portal vein ligation
Apatinib

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations